Preformed Line Products (PLPC) Form 4: Director Gibbons Receives 117 Shares
Rhea-AI Filing Summary
Form 4 filing overview — Preformed Line Products Co. (PLPC)
Director Michael E. Gibbons reported one transaction dated 07/01/2025 under the company’s Directors Deferred Compensation Plan. Mr. Gibbons elected to defer 2025 director fees, causing the company to credit a rabbi trust with 117 common shares of PLPC at an acquisition price of $159.81 per share. Following the credit, the trust holds 14,608 shares on Mr. Gibbons’ behalf. A separate line shows 2,961 common shares with a disposition marker (D), but the filing does not provide a transaction date, price, or narrative for this item.
No derivative securities were reported, and there were no open-market purchases or sales by the director personally; the activity is entirely related to deferred compensation.
- The transaction is routine, non-cash and not likely to be materially impactful for shareholders.
- No earnings data, strategic developments, or changes in beneficial ownership percentages were disclosed.
Positive
- Insider share acquisition (117 shares) indicates continued participation in equity-based compensation, aligning director interests with shareholders.
- Timely Form 4 filing demonstrates PLPC’s compliance and transparency with Section 16 obligations.
Negative
- Transaction size is immaterial; 117 shares have negligible impact on ownership structure or market perception.
- Unclarified 2,961-share disposition creates minor disclosure ambiguity, though no price or date suggests limited relevance.
Insights
TL;DR – Routine deferred-comp transaction; negligible market impact.
The 117-share credit represents less than 1 % of daily PLPC volume and stems from a standard fee-deferral election, not insider sentiment. Total indirect holdings now stand at 14,608 shares, so ownership dilution or enhancement is immaterial. Because the shares reside in a rabbi trust, Mr. Gibbons cannot trade them freely, further limiting signaling value. The unlabeled 2,961-share disposition lacks context, preventing assessment. Overall, the filing does not change the investment thesis on PLPC.
TL;DR – Compliance-driven disclosure, signals proper governance.
The company adheres to Section 16 reporting by promptly disclosing deferred-compensation share allocations. Use of a rabbi trust aligns with best practices, keeping plan assets unfunded and subject to creditor risk, thereby avoiding constructive receipt for the director. No red flags emerge; however, the unexplained 2,961-share ‘D’ line would benefit from clarification in future filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common shares, $2 par value | 117 | $159.81 | $19K |
| holding | Common shares, $2 par value | -- | -- | -- |
Footnotes (1)
- F1. Represents Company common shares held by a Rabbi Trust pursuant to the Reporting Person's election to defer 2025 directors' fees under the Company's Directors Deferred Compensation Plan (the "Plan"). Deferred amounts under the Plan shall be paid to the Reporting Person in a distribution of Company common shares.
FAQ
Does this Form 4 indicate an open-market purchase by the director?
What is the director’s total indirect holding after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.
